Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Direct costs attributable to producing goods sold
3Y CAGR
+160.4%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
17.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $265000.00 | -68.4% |
| 2024 | $839000.00 | +649.1% |
| 2023 | $112000.00 | +646.7% |
| 2022 | $15000.00 | - |